PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
19-Jun-2020 Max Planck researchers feed Proteome AI with PharmaFluidics technology PharmaFluidics
19-Jun-2020 National expansion of Synairgen’s home-based COVID-19 trial of inhaled SNG001 Synairgen plc
19-Jun-2020 Chi-Med Announces Fruquintinib Granted U.S. FDA Fast Track Designation for Metastatic Colorectal Cancer Chi-Med
19-Jun-2020 Cancer’s reliance on fat could be targeted with new ‘drugs and diet’ treatment The Institute of Cancer Research
19-Jun-2020 4D hosts virtual R&D event providing updates on clinical programmes in oncology and COVID-19 4D pharma plc
17-Jun-2020 Switching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice Novo Nordisk
17-Jun-2020 Faron receives €2.1 million funding from Business Finland for Traumakine manufacturing Faron Pharmaceuticals Ltd
17-Jun-2020 Kyowa Kirin makes POTELIGEO® (mogamulizumab) available in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome, Two Rare Forms of Non-Hodgkin’s Lymphoma with High Unmet Medical Need Kyowa Kirin
17-Jun-2020 New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Celltrion Healthcare
17-Jun-2020 Wipro launches Digital Inspection Solution powered by IBM® TRIRIGA® Wipro Limited
17-Jun-2020 Rybelsus® was more effective in achieving clinically relevant blood sugar and weight reductions in people with type 2 diabetes vs all active comparators Novo Nordisk
17-Jun-2020 UPS HEALTHCARE CONTINUES GLOBAL FACILITY EXPANSION TO MEET GROWING DEMANDS IN KEY MARKETS UPS Healthcare
17-Jun-2020 New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Celltrion Healthcare
17-Jun-2020 Faron provides update on pipeline progress ahead of R&D Day Faron Pharmaceuticals Oy
17-Jun-2020 New Data from Phase 3 Studies Support Maintained Transfusion Independence* for Patients Across Genotypes Treated with betibeglogene autotemcel (LentiGlobin for β-thalassaemia) Gene Therapy bluebird bio
17-Jun-2020 PureTech Founded Entity Akili Announces FDA Clearance of EndeavorRxTM for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game PureTech Health
17-Jun-2020 Ona Therapeutics raises €30M in Series A financing Ona Therapeutics
17-Jun-2020 TILT Biotherapeutics secures over EUR 6 million to advance cancer immunotherapies into clinic TILT Biotherapeutics
17-Jun-2020 DATA VISUALISATION COMPANY ZEGAMI LAUNCHES NEW SCHEME INVITING SCIENTISTS AND RESEARCHERS WORKING ON MEDICAL IMAGING TO APPLY TO USE ITS SOFTWARE FOR FREE Oxford University
17-Jun-2020 GC Aesthetics introduces the GCA Comfort Plus Warranty - the new lifetime warranty GC Aesthetics